LEPU BIO-B (02157) Enters into CDMO Service Framework Agreement with Lepu Medical

Stock News

11/28

LEPU BIO-B (02157) announced on November 28, 2025, that the company has signed a CDMO service framework agreement with Lepu Medical Technology (Beijing) Co., Ltd. Under the agreement, LEPU BIO-B and/or its subsidiaries will provide CDMO technical services to Lepu Medical and/or its affiliates.

Beyond meeting its own clinical trial and commercialization demands for drug production, the group can now utilize excess capacity more efficiently when suitable business opportunities arise. The board believes that this agreement will optimize the use of surplus production capabilities and generate supplementary cash flow for the group.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1186478247"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186478247\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186478247?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-28 16:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186478247","market":"fut","top_or_hot":-1,"title":"LEPU BIO-B (02157) Enters into CDMO Service Framework Agreement with Lepu Medical","media":"Stock News","content":"<p>LEPU BIO-B (02157) announced on November 28, 2025, that the company has signed a CDMO service framework agreement with Lepu Medical Technology (Beijing) Co., Ltd. Under the agreement, LEPU BIO-B and/or its subsidiaries will provide CDMO technical services to Lepu Medical and/or its affiliates.</p>\n<p>Beyond meeting its own clinical trial and commercialization demands for drug production, the group can now utilize excess capacity more efficiently when suitable business opportunities arise. The board believes that this agreement will optimize the use of surplus production capabilities and generate supplementary cash flow for the group.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEPU BIO-B (02157) Enters into CDMO Service Framework Agreement with Lepu Medical</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEPU BIO-B (02157) Enters into CDMO Service Framework Agreement with Lepu Medical\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-28 16:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LEPU BIO-B (02157) announced on November 28, 2025, that the company has signed a CDMO service framework agreement with Lepu Medical Technology (Beijing) Co., Ltd. Under the agreement, LEPU BIO-B and/or its subsidiaries will provide CDMO technical services to Lepu Medical and/or its affiliates.</p>\n<p>Beyond meeting its own clinical trial and commercialization demands for drug production, the group can now utilize excess capacity more efficiently when suitable business opportunities arise. The board believes that this agreement will optimize the use of surplus production capabilities and generate supplementary cash flow for the group.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1186478247","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186478247","pubTimestamp":1764319813,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"LEPU BIO-B (02157) announced on November 28, 2025, that the company has signed a CDMO service framework agreement with Lepu Medical Technology (Beijing) Co., Ltd. Under the agreement, LEPU BIO-B...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300003":"乐普医疗","BK1161":"生物科技","BK0114":"健康中国","BK0196":"行业龙头","BK4139":"生物科技","BK0042":"基因检测","CDMO":"Avid Bioservices, Inc.","BK0028":"国家队","BK0188":"融资融券","BK0251":"专用设备","02157":"乐普生物-B","BK0201":"可转债","BK0113":"养老产业"},"translate_title":"乐普生物-B(02157)与乐普医疗订立CDMO服务框架协议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300003":1,"CDMO":1,"02157":1},"content_text":"LEPU BIO-B (02157) announced on November 28, 2025, that the company has signed a CDMO service framework agreement with Lepu Medical Technology (Beijing) Co., Ltd. Under the agreement, LEPU BIO-B and/or its subsidiaries will provide CDMO technical services to Lepu Medical and/or its affiliates.\nBeyond meeting its own clinical trial and commercialization demands for drug production, the group can now utilize excess capacity more efficiently when suitable business opportunities arise. The board believes that this agreement will optimize the use of surplus production capabilities and generate supplementary cash flow for the group.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}